Drug Trial Radar · NCT00474708
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Last checked: Nov 20, 2026Latest source record: Mar 5, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,151
Actual
Start
Apr 2007
Primary completion
Mar 2008
Study completion Mar 2008
Sponsor
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 17, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is an open-label, randomized, multi-center study conducted in a typical psychiatric outpatient practice in China. This study is intended to collect data on the efficacy and safety of venlafaxine XR (Efexor XR®) versus SSRIs and conventional antidepressants in depressed patients that previously failed antidepressant treatment. This data will be used to guide psychiatrists on recommendations for clinic use.
Conditions
- Major Depressive Disorder
Interventions
EffexorDrug
SSRIDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients Achieving RemissionTime frame: 12 weeks
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Beijing, Beijing Municipality, China
Site not named
Beijing, Beijing Municipality, China
Site not named
Beijing, Beijing Municipality, China
Site not named
Guangzhou, Guangdong, China
Site not named
Guangzhou, Guangdong, China
Site not named
Guangzhou, Guangdong, China
Site not named
Guangzhou, Guangdong, China
Site not named
Zhengzhou, Henan, China
Site not named
Wuhan, Hubei, China
Site not named
Changsha, Hunan, China
Site not named
Nanjing, Jiangsu, China
Site not named
Shenyang, Liaoning, China
Site not named
Jinan, Shandong, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Shanghai, Shanghai Municipality, China
Site not named
Xian, Shanxi, China
Site not named
Tianjin, Tianjin Municipality, China
Site not named
Hangzhou, Zhejiang, China
Site not named
Hangzhou, Zhejiang, China
Site not named
Huzhou, Zhejiang, China
Site not named
Suzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.